This brand name is authorized in South Africa
The drug VOXIDEX contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Dexamethasone
UNII AI9376Y64P - DEXAMETHASONE SODIUM PHOSPHATE
|
|
Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response. |
|
2
Levofloxacin
UNII 6GNT3Y5LMF - LEVOFLOXACIN
|
|
Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| VOXIDEX Eye drops, solution | Health Products Regulatory Authority (ZA) | MPI, Generic |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 54/15.3/0836 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
